GENLINK3D
LIVE

Serial Number

97691779

Owner

ENHANC3D GENOMICS LTD

Attorney

Emily M. Chilson

Filing Date

Nov 25, 2022

Add to watchlist:

No watchlists yet
View on USPTO

GENLINK3D Trademark

Serial Number: 97691779 • Registration: 7895843

GENLINK3D is a trademark filed by ENHANC3D GENOMICS LTD on November 25, 2022. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

ENHANC3D GENOMICS LTD (3 trademarks)

Babraham Research Campus
Cambridge CB223AT , GB

Entity Type: 99

ENHANCED GENOMICS (3 trademarks)

SUITE 1, THE JEFFREYS BUILDING, ST JOHN'S INNOVATION PARK, COWLEY ROAD
CAMBRIDGE CB4 0DS , GB

Entity Type: 78

Trademark Details

Filing Date

November 25, 2022

Registration Date

August 19, 2025

Published for Opposition

June 3, 2025

Goods & Services

Downloadable software for profiling three-dimensional genome folding at high resolution for all genes and their enhancers; Downloadable software for visualisation, analysis, and manipulation of biological molecules in the field of genomics; Downloadable software for visualisation, analysis, and manipulation of biological molecules; Downloadable software for modelling and prediction of biological interactions; Downloadable software for genome sequencing; Scientific research apparatus and instruments being laboratory devices for detecting genetic sequences by profiling three-dimensional genome folding at high resolution for all genes and their enhancers; Electronic database in the field of genomics recorded on computer media; Downloadable educational publications, namely, printable workbooks, booklets, scientific journals, and articles in the field of genomics; Downloadable electronic publications in the nature of scientific journals and articles in the field of drug discovery; Downloadable electronic publications in the nature of scientific journals and articles in the field of medical diagnosis; Downloadable electronic publications in the nature of scientific journals and articles in the field of biomarker discovery; Downloadable electronic publications in the nature of scientific journals and articles in the field of genomics; Downloadable electronic publications in the nature of scientific journals and articles in the field of bioinformatics

Business data analysis in the field of drug discovery; Business data analysis in the field of medical diagnosis; Business data analysis in the field of biomarker discovery; Business data analysis in the field of genomics; Business data analysis in the field of bioinformatics; Data processing in the field of drug discovery; Data processing in the field of medical diagnosis; Data processing in the field of biomarker discovery; Data processing in the field of genomics; Data processing in the field of bioinformatics; Database management; Database management and statistical reporting services for business purposes; Business information services in the fields of medical diagnosis, biomarker discovery, genomics, and bioinformatics; Business consulting services in the fields of medical diagnosis, biomarker discovery, genomics, and bioinformatics; Business consulting services in the field of drug discovery; Business consulting services in the field of biomarker discovery; Market intelligence services in the fields of medical diagnosis, biomarker discovery, genomics, and bioinformatics; Electronic data collection and data submission services for business purposes in the fields of medicine and healthcare; Business advisory services, consultancy and information

Software as a service (SAAS) services featuring software for profiling three-dimensional genome folding at high resolution for all genes and their enhancers; Software as a service (SAAS) services featuring software for analyzing biological data for research and development of drugs in the field of genomics; Software as a service (SAAS) services featuring software for diagnosis of genetic diseases by analyzing biological data; Software as a service (SAAS) services featuring software for development of biomarkers for medical treatment; Software as a service (SAAS) services featuring software for collection, analysis and interpretation of biological data; Software as a service (SaaS) services featuring software for visualisation, analysis, and manipulation of biological molecules; Software as a service (SaaS) services featuring software for modelling and prediction of biological interactions; Software as a service (SaaS) services featuring software for genome sequencing; Software as a service (SAAS) services featuring software for data analysis, data processing and database management in the field of genomics; Software as a service (SAAS) services featuring software for data analysis for research and development of artificial intelligence and machine learning in the field of genomics; Platform as a service (PAAS) featuring computer software platforms for data analysis, data processing and database management in the field of genomics; Platform as a service (PAAS) featuring computer software platforms for analyzing biological data for research and development of drugs in the field of genomics; Platform as a service (PAAS) featuring computer software platforms for diagnosis of genetic diseases by collecting and analyzing biological data; Platform as a service (PAAS) featuring computer software platforms for development of biomarkers for medical treatment; Platform as a service (PAAS) featuring computer software platforms for profiling three-dimensional genome folding at high resolution for all genes and their enhancers; Platform as a service (PAAS) featuring computer software platforms for collection, analysis and interpretation of biological data; Platform as a service (PaaS) featuring computer software platforms for visualisation, analysis, and manipulation of biological molecules; Platform as a service (PaaS) featuring computer software platforms for modelling and prediction of biological interactions; Platform as a service (PaaS) featuring computer software platforms for genome sequencing; Platform as a service (PaaS) featuring computer software platforms for performing data analysis, data processing, and database management in the fields of medical diagnosis, biomarker discovery, genomics, and bioinformatics; Platform as a service (PaaS) featuring computer software platforms using artificial intelligence for machine learning in the field of genomics; Design and development of software for profiling three-dimensional genome folding at high resolution for all genes and their enhancers; Design and development of computer software in the field of data analysis for drug discovery; Design and development of computer software in the field of data analysis for medical diagnosis; Design and development of computer software in the field of collection and analysis of biological data for biomarker discovery; Design and development of computer software in the field of genomic analysis; Design and development of computer software in the field of bioinformatic analysis; Design and development of computer software for visualisation, analysis, and manipulation of biological molecules; Design and development of computer software for modelling and prediction of biological interactions; Design and development of computer software for genome sequencing; Design and development of computer software for performing data analysis in the fields of medical diagnosis, biomarker discovery, genomics, and bioinformatics; Design and development of computer software using artificial intelligence for machine learning in the field of genomics; Scientific research services for others in the field of genomics; Scientific research services for others in the field of drug discovery; Scientific research services for others in the field of medical diagnosis; Scientific research services for others in the field of biomarker discovery; Scientific research services for others in the field of bioinformatics; Scientific research consulting services in the field of drug discovery; Scientific research consulting services in the field of medical diagnosis; Scientific research consulting services in the field of biomarker discovery; Scientific research consulting services in the field of genomics; Scientific research consulting services in the field of bioinformatics; Scientific and technological services, namely, scientific research and analysis featuring profiling three-dimensional genome folding at high resolution for all genes and their enhancers, in the field of genomics; Scientific and technological services, namely, scientific testing in the field of drug discovery; Scientific and technological services, namely, scientific testing in the field of medical diagnosis; Scientific and technological services, namely, scientific testing in the field of biomarker discovery; Scientific and technological services, namely, scientific testing in the field of genomics; Scientific and technological services, namely, scientific testing in the field of bioinformatics; Computer programming services for scientific data processing; Providing temporary use of on-line non-downloadable software for profiling three-dimensional genome folding at high resolution for all genes and their enhancers; Compiling data for research purposes in the field of medical science; Advisory services relating to computer software design for genomic analysis; Consultancy in the field of software design for genomic analysis; Providing information in the field of scientific research in the field of genomics; Compiling data for scientific research purposes in the field of medical science

Filing History

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Oct 15, 2025 ASGN
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Aug 19, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Aug 19, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 3, 2025 NPUB
PUBLISHED FOR OPPOSITION
Jun 3, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 28, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 5, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 8, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 8, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 8, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 11, 2025 GNRN
NON-FINAL ACTION E-MAILED
Jan 11, 2025 GNRT
NON-FINAL ACTION WRITTEN
Jan 11, 2025 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 2, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 2, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 2, 2024 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Sep 3, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Sep 3, 2024 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 3, 2024 GNRN
NON-FINAL ACTION E-MAILED
Jun 3, 2024 GNRT
NON-FINAL ACTION WRITTEN
Jun 3, 2024 CNRT
ASSIGNED TO EXAMINER
Apr 18, 2024 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 13, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 13, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 13, 2024 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Dec 13, 2023 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Dec 13, 2023 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 18, 2023 GNRN
NON-FINAL ACTION E-MAILED
Sep 18, 2023 GNRT
NON-FINAL ACTION WRITTEN
Sep 18, 2023 CNRT
ASSIGNED TO EXAMINER
Sep 6, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 18, 2022 NWOS
NEW APPLICATION ENTERED
Nov 29, 2022 NWAP